Having trouble viewing this message? Read the online version.

Inspiring the Future of Science & Innovation with Leadership and Global Vision
IBC's 5th Annual China 2010 Pharmaceutical R&D Summit
April 5-8, 2010 · Grand Hyatt Hotel · Shanghai, China
Register at: www.IBCLifeSciences.com/China
China-Based Companies Save 20% off the standard rate
International Companies Save 30% off the standard rate
Use Priority Code: R10163SAPA
Tel: +(65) 6514 3180 or 646-895-7445

Announcing the 2010 conference program:
Organized by:
IBC Life Sciences
Bronze Sponsors:
Excel PharmaStudies, Inc
INC Research
MPI Research
Event Partners:
Sino-American Pharmaceutical Professionals Association (SAPA)
BayHelix
Supporting Organizations:
SABPA - Sino-American Biotechnology and Pharmaceutical Professionals Association
Chinese Biopharmaceutical Association
ChinaBio Accelerator
Contract Research Organization Union (CROU)

Dear Colleague

The past year has seen a lot of major changes in the global pharmaceutical industry. The global economic recession is forcing companies to make hard decisions to reduce redundancies, streamline workflow, develop new business models as well as exploit new opportunities in domestic and overseas markets. Emerging markets like China take center-stage as big pharma and biotechs realize the increasing potential of these developing countries and the impact it has on the companies' global strategies.

We invite you to attend China 2010 Pharmaceutical R&D Summit to HEAR from these internationally renowned Keynote Speakers on their restructured models and emerging market strategies:

  • Martin Mackay, Ph.D., President PharmaTherapeutics R&D, Pfizer Inc.
  • Marc Cluzel, Ph.D., M.D., Executive Vice President, R&D, Sanofi-Aventis
  • Piao-Yang Sun, Ph.D., CEO & Chairman of the Board, Jiangsu Hengrui Medicine Co., Ltd.
  • Michel Vounatsos, M.D., President, MSD China

And don't miss these unique presentations from our Featured Speakers on public-private partnerships to develop drugs for the unmet medical needs for developing countries:

  • Robert Ridley, Ph.D., Director, Special Program for Research, TDR, World Health Organization
  • Kanwarjit Singh, M.D., MBA, Senior Program Officer, Global Health, Bill & Melinda Gates Foundation

Other Exciting Conference Highlights include:

  • China R&D Leaders' Roundtable - China's Pharmaceutical Industry from the Insiders' Eyes
  • Investment Panel - The Future of Biotech Investing in China
  • Impact of China's Healthcare Reform on MNCs and Domestic Companies
  • Other Emerging Markets vis-a-vis China
  • Academic Research & Scientific Advances
  • Clinical Development Strategies - from FIH to Post-Marketing Studies
  • Biologics & Biosimilars Development - from Global Outlook to Local R&D

Nominate a candidate for IBC's 1st China Pharma R&D Awards!

In conjunction with SAPA and BayHelix, IBC is honored to host the first IBC China Pharma R&D Awards for the following 3 categories:

  • IBC China Scientific Discovery of the Year Award
  • IBC China Drug Discovery of the Year Award
  • IBC China R&D Award

To nominate a potential candidate for the Awards, please fill out the Nominations Form and return the form to Mimi Langley at mlangley@ibcusa.com by February 25th, 2010. For more information visit www.ibclifesciences.com/china/awards.xml

Registration Information:

China-Based Companies Save 20% off the standard rate
International Companies Save 30% off the standard rate
Use registration priority code R10163SAPA.
Phone: +(65) 6514 3180
Email: register@ibcasia.com.sg
Web: www.IBCLifeSciences.com/China